Eight Roads

Overview

Eight Roads is a global venture capital firm founded in 1969, managing approximately $8-11 billion in assets under management across offices in Asia, Europe, and the US. It invests in early to growth-stage technology and healthcare companies, with a portfolio exceeding 300 active companies including 19 unicorns. The firm operates as the proprietary investment arm of Fidelity International, focusing on sectors like AI, fintech, consumer, and healthcare IT through funds targeting Series A to growth equity investments of $5-50 million.¹²³⁴

History

Eight Roads was founded in 1969 as Fidelity Ventures and rebranded over time into its current form as the corporate investment arm of Fidelity International. It has expanded from its origins to establish offices in key markets including London, Boston, Bangalore, Beijing, Hong Kong, Mumbai, Shanghai, and Tokyo. Key milestones include managing over $11 billion in AUM, backing more than 350 companies with over 60 IPOs, and launching recent funds such as a $375 million Europe and Israel-focused fund in 2025. The firm remains active, with 15 investments in the past 12 months as of December 2025.¹²³⁵

Notable Products

• Eight Roads China Technology Fund V - Closed in October 2023, focusing on technology investments in China.
• Europe and Israel Fund ($375M) - Launched recently for enterprise tech, consumer, fintech, and healthcare IT investments of $10-30M each.

Reputation

Eight Roads is regarded by professionals as a established player in global VC with strong local expertise across Asia and Europe, evidenced by its large portfolio and support for scaling startups. Enthusiasts note its Fidelity backing and track record of 19 unicorns and 60+ IPOs as strengths. Criticisms are limited in available sources, though its captive nature may constrain independence compared to pure-play VCs.¹²⁴